Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Go back to Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
(NASDAQ: XENE) Delayed: 69.95 --0 (-0%)
Previous Close $69.95    52 Week High $9.75 
Open $69.95    52 Week Low $5.65 
Day High $69.95    P/E N/A 
Day Low $69.95    EPS $0.00 
Volume 2,934       

(NASDAQ: XENE) Delayed: 69.95 --0 (-0%)
Previous Close $69.95    52 Week High $9.75 
Open $69.95    52 Week Low $5.65 
Day High $69.95    P/E N/A 
Day Low $69.95    EPS $0.00 
Volume 2,934